Patient Front Groups Loot Medicare Dollars for Big Pharma

by MARTHA ROSENBERG

The Obama administration is finally addressing the expensive, dangerous and usually unnecessary psychiatric drugs that are footed by taxpayers in federal entitlement programs. It has proposed that insurers may limit Medicare coverage of certain classes of drugs that include Wellbutrin, Paxil and Prozac for depression and Abilify and Seroquel for schizophrenia.

How expensive are these drugs? 100 middle dose pills of the widely marketed Abilify cost as much as $1,644. 100 pills of Geodon are $958, Invega, $1,789, Risperdal, $953, Seroquel, $2,000 and Zyprexa, $1,680, if the brand name drugs are used, which drug company  lobbyists hope. Thanks to their lobbying, insurers have to pay “all or substantially all” of such depression and schizophrenia drug costs because the drugs enjoy “protected status” in the Medicare program. Such protected pills account for as much as 33 percent of total outpatient drug spending under Part D of Medicare, says the New York Times.

Not surprisingly, Big Pharma and its patient front groups are livid that the heisting of US taxpayers dollars could be curtailed. Abilify alone has earned over $4 billion a year! “The proposal undermines a key protection for some of the sickest, most vulnerable Medicare beneficiaries,” said Andrew Sperling, a lobbyist at the National Alliance on Mental Illness (NAMI) which is fighting the Obama proposal.

As much as 75 percent of NAMI’s donations come from drug companies says the New York Times and it has been investigated by Congress. Portraying itself as “patients,” NAMI also successfully fights states’ efforts to limit use of the most pricey Medicaid psychiatric drugs, in parallel lobbying. “Some of these medicines routinely top the list of the most expensive drugs that states buy for their poorest patients,” says the Times. NAMI is “hugely influential in many state capitols,” it adds.

The heart of Big Pharma and NAMI lobbying is making sure expensive drugs are on Medicare and Medicaid formularies and that doctors prescribe them first–before and instead of lower priced drugs. The expensive-drugs-first marketing is couched as “patient choice” or another “treatment option” by Pharma lobbyists as if there’s no difference between a $45 prescription and $450 prescription. Antipsychotic drugs work in different ways in the body explains Sperling and “You get much better outcomes when a doctor can work with patients to figure out which medications will work best for them.” Ka-ching.

The problem is newer, more expensive drugs are not necessarily better than older, less expensive drugs and they are often more dangerous. One chilling example is an estimated 15,000 elderly people die in nursing homes a year from inappropriately given antipsychotic medications, according to FDA drug reviewer David Graham, MD.  Pharma is aware of the profiteering and “laughing all the way to the bank,” Graham speculated.

Antipsychotics like Seroquel carry warnings that they cause death in elderly people who have dementia but are nevertheless in wide use in many geriatric, federally-supported facilities. So much for NAMI’s concern for “the sickest, most vulnerable Medicare beneficiaries.”

NAMI is not the only group to play on the public’s heart strings to keep drug revenues flowing. Pharma’s aggressive opioid lobby says patients with legitimate pain will suffer if drugs like Oxycontin, killing 17,000 Americans a year, are regulated. Similarly, if Abilify and Seroquel are regulated within Medicare, someone will suffer–Big Pharma.

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

 

 

 

 

 

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

Like What You’ve Read? Support CounterPunch
July 30, 2015
Bill Blunden
The NSA’s 9/11 Cover-Up: General Hayden Told a Lie, and It’s a Whopper
Richard Ward
Sandra Bland, Rebel
Jeffrey St. Clair
How One Safari Nut, the CIA and Neoliberal Environmentalists Plotted to Destroy Mozambique
Martha Rosenberg
Tracking the Lion Killers Back to the Old Oval Office
Binoy Kampmark
Dead Again: the Latest Demise of Mullah Omar
Kathy Kelly – Buddy Bell
No Warlords Need Apply: a Call for Credible Peacemaking in Afghanistan
Ramzy Baroud
Darker Horizons Ahead: Rethinking the War on ‘IS’
Stephen Lendman
The Show Trial of Saif Qaddafi: a Manufactured Death Sentence
John Grant
The United States of Absurdity, Circa 2015
Karl Grossman
The Case of John Peter Zenger and the Fight for a Free Press
Cesar Chelala
Cultural Treasures Are Also Victims of War
Jeff Taylor
Iowa Conference on Presidential Politics
July 29, 2015
Mike Whitney
The Politics of Betrayal: Obama Backstabs Kurds to Appease Turkey
Joshua Frank
The Wheels Fell Off the Bernie Sanders Bandwagon
Conn Hallinan
Ukraine: Close to the Edge
Stephen Lendman
What Happened to Ralkina Jones? Another Jail Cell Death
Rob Wallace
Neoliberal Ebola: the Agroeconomic Origins of the Ebola Outbreak
Dmitry Rodionov
The ‘Ichkerization’ Crime Wave in Ukraine
Joyce Nelson
Scott Walker & Stephen Harper: a New Bromance
Bill Blunden
The Red Herring of Digital Backdoors and Key Escrow Encryption
Thomas Mountain
The Sheepdog Politics of Barack Obama
Farzana Versey
A President and a Yogi: Abdul Kalam’s Symbolism
Norman Pollack
America’s Decline: Internal Structural-Cultural Subversion
Foday Darboe
How Obama Failed Africa
Cesar Chelala
Russia’s Insidious Epidemic
Tom H. Hastings
Defending Democracy
David Macaray
Why Union Contracts are Good for the Country
Virginia Arthur
The High and Dry Sierras
Jon Langford
Mekons Tour Diary, the Season Finale, Mekonception in Redhook
July 28, 2015
Mark Schuller
Humanitarian Occupation of Haiti: 100 Years and Counting
Lawrence Ware
Why the “Black Church” Doesn’t Exist–and Never Has
Peter Makhlouf
Israel and Gaza: the BDS Movement One Year After “Protective Edge”
Carl Finamore
Landlords Behaving Badly: San Francisco Too Valuable for Poor People*
Michael P. Bradley
Educating About Islam: Problems of Selectivity and Imbalance
Binoy Kampmark
Ransacking Malaysia: the Najib Corruption Dossier
Michael Avender - Medea Benjamin
El Salvador’s Draconian Abortion Laws: a Miscarriage of Justice
Jesse Jackson
Sandra Bland’s Only Crime Was Driving While Black
Cesar Chelala
Effect of Greece’s Economic Crisis on Public Health
Mel Gurtov
Netanyahu: An Enemy of Peace
Joseph G. Ramsey
The Limits of Optimism: E.L. Doctorow and the American Left
George Wuerthner
Bark Beetles and Forest Fires: Another Myth Goes Up in Smoke
Paul Craig Roberts - Dave Kranzler
Supply and Demand in the Gold and Silver Futures Markets
Eric Draitser
China’s NGO Law: Countering Western Soft Power and Subversion
Harvey Wasserman
Will Ohio Gov. Kasich’s Anti-Green Resume Kill His Presidential Hopes?
Jon Langford
Mekons Tour Diary, Episode 4, a Bowery Ballroom Blitz